Today, a Director at Aldeyra Therapeutics (ALDX), Jesse Treu, sold shares of ALDX for $968.4K.
See today’s analyst top recommended stocks >>
Currently, Aldeyra Therapeutics has an average volume of 1.31M.
Jesse Treu’s trades have generated a -8.0% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes.
